Tenshi Life Sciences Pte. Limited Sells 77,000 Shares of KDA Group Inc. (CVE:KDA) Stock

KDA Group Inc. (CVE:KDA) insider Tenshi Life Sciences Pte. Limited sold 77,000 shares of the stock in a transaction that occurred on Wednesday, September 25th. The shares were sold at an average price of C$0.30, for a total transaction of C$23,100.00.

Tenshi Life Sciences Pte. Limited also recently made the following trade(s):

• On Monday, September 23rd, Tenshi Life Sciences Pte. Limited sold 43,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total transaction of C$13,050.00.
• On Tuesday, September 17th, Tenshi Life Sciences Pte. Limited sold 24,500 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total transaction of C$7,350.00.
• On Wednesday, August 28th, Tenshi Life Sciences Pte. Limited sold 160,500 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total transaction of C$48,150.00.
• On Monday, July 15th, Tenshi Life Sciences Pte. Limited sold 51,000 shares of KDA Group stock. The stock was sold at an average price of C$0.32, for a total value of C$16,105.80.
• On Friday, July 12th, Tenshi Life Sciences Pte. Limited sold 50,500 shares of KDA Group stock. The shares were sold at an average price of C$0.30, for a total value of C$15,150.00.
• On Wednesday, July 10th, Tenshi Life Sciences Pte. Limited sold 458,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$137,550.00.

KDA Group Trading Down 1.8 %

KDA stock opened at C$0.28 on Friday. The firm has a fifty day moving average price of C$0.26 and a 200 day moving average price of C$0.34. KDA Group Inc. has a fifty-two week low of C$0.08 and a fifty-two week high of C$0.66. The firm has a market cap of C$49.11 million, a PE ratio of -7.50 and a beta of 1.23. The company has a debt-to-equity ratio of 7.36, a quick ratio of 0.35 and a current ratio of 2.10.

KDA Group Company Profile

KDA Group Inc, together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.